Seeking Alpha

Seeking Alpha Portfolio App for iPad

Bio Vantage

Bio Vantage picture

Profile

Send Message

View as an RSS Feed

View Bio Vantage's Articles BY TICKER:

Our Model Suggests An Intrinsic Value Of $117 For Amgen
on Wed, Apr 3 • AMGN • 5 Comments
Four Factors Driving Amgen's Stock Price To $102
on Mon, Apr 1 • ABBV, BMY, JNJ • 4 Comments
What Is Johnson & Johnson's Fair Value After Invokana Approval?
on Sun, Mar 31 • JNJ • 5 Comments
How Much Will FDA Action On Invokana Affect Johnson & Johnson's Revenue And Stock Price?
on Thu, Mar 28 • AZN, BMY, MRK • 4 Comments
Is Pfizer Overvalued At $28.5?
on Wed, Mar 27 • PFE • 10 Comments
Pharmacyclics, Part 4: Financial Projection And Stock Valuation
on Mon, Feb 25 • JNJ, PCYC • Comment!
Pharmacyclics, Part 3: Financials And Its Partnership With Johnson And Johnson
on Mon, Feb 25 • JNJ, PCYC • Comment!
Pharmacyclics, Part 2: How Much Revenue Could Ibrutinib Generate?
on Mon, Feb 25 • JNJ, PCYC • 1 Comment
Pharmacyclics, Part 1: Can The Incredible Run Continue?
on Mon, Feb 25 • JNJ, PCYC • Comment!
Pfizer: Financial Projection And Stock Valuation
on Thu, Feb 14 • ZTS, PFE • 7 Comments
How Much Will Pfizer's New Drugs Contribute To Future Revenue?
on Wed, Feb 13 • PFE • 2 Comments
What Does Pfizer's 2012 Earnings Tell Us About Its Operations?
on Tue, Feb 12 • PFE • 1 Comment
What Is The Fair Value For Apple In The Newtonian World?
on Mon, Jan 28 • GOOG, INTC, MSFT • 21 Comments
Amgen: Equity Report And Stock Valuation
on Mon, Dec 3, 2012 • ABT, PFE, JNJ • 2 Comments
Amarin: Limited Downside With Significant Upside
on Fri, Nov 16, 2012 • AMRN • 16 Comments
Amarin's Dilemma: Sell Vascepa Or Sell Itself?
on Tue, Nov 13, 2012 • AMRN • 5 Comments
Dynavax Upcoming Binary Event: HBV Vaccine Under Review By FDA Advisory Panel
on Mon, Nov 12, 2012 • AZN, GSK, MRK • 4 Comments
Pfizer's Future May Hinge On Tofacitinib FDA Action In November
on Thu, Nov 1, 2012 • PFE • 1 Comment
Valuing Berkshire Hathaway: The Basics
on Wed, Oct 31, 2012 • BRK.B, BRK.A • 3 Comments
A Post-Lipitor Pfizer: Financial Projection And Stock Valuation
on Wed, Oct 24, 2012 • PFE • 5 Comments
Could Tofacitinib Save Pfizer?
on Tue, Oct 23, 2012 • JNJ, LLY, PFE • 4 Comments
Mini iPads Could Be A Mega Apple Hit
on Mon, Oct 22, 2012 • AAPL • 18 Comments
Lipitor's Patent Expiration: How Much Will It Impact Pfizer's Revenue And Earnings In 2012?
on Fri, Oct 19, 2012 • PFE • 4 Comments
Trillion-Dollar Strategies For Apple: An Investor's Letter To Tim Cook
on Tue, Oct 2, 2012 • AAPL • 48 Comments
Johnson & Johnson Stock Valuation - Part 4
on Mon, Sep 10, 2012 • JNJ • 13 Comments
Is Amarin Positioned To Be A Takeover Target?
on Mon, Sep 10, 2012 • AMRN • 11 Comments
Johnson & Johnson Stock Valuation - Part 3
on Thu, Sep 6, 2012 • ABT, ALKS, DNDN • 2 Comments
Johnson & Johnson Stock Valuation - Part 2
on Wed, Sep 5, 2012 • JNJ • Comment!
Johnson & Johnson Stock Valuation - Part 1
on Wed, Sep 5, 2012 • BMY, SNY, LLY • 4 Comments
What Is The True P/E Multiple For Berkshire Hathaway?
on Fri, Aug 17, 2012 • KO, BRK.A, BRK.B • 18 Comments
Vivus Holds Strong Patent Portfolio For Qsymia
on Wed, Aug 1, 2012 • JNJ, VVUS • 25 Comments
Amarin Valuation Before FDA Action
on Thu, Jul 12, 2012 • AMRN • 27 Comments